PHSSR Policy Roadmaps for Acting Early on NCDs Synthesis Report 2025

111 Acting early on NCDs The Partnership for Health System Sustainability and ResilienceHealth and Global Policy Institute (HGPI) et al. (2023). Joint Statement on the Implementation of Comprehensive Genomic Profiling Test. Tokyo: HGPI. Health Canada. (2024). Health Canada Acts and Regulations. Ottawa: Government of Canada. Health Canada. (2025a). Federal Provincial Territorial Health Ministers’ Meeting. Ottawa: Government of Canada. Health Canada. (2025b). Caring for Canadians: Canada’s future health workforce – The Canadian health workforce education, training and distribution study. Ottawa: Government of Canada. Health Effects Institute. (2024). State of Global Air 2024. Boston: HEI. Health Needs Maps. (2025). [Mapy Potrzeb Zdrowotnych]. Warsaw: Ministry of Health. HeartLife Foundation. (2024a). Landmark National Framework on Heart Failure Act Tabled in Canadian Senate. Ottawa: HeartLife Foundation. HeartLife Foundation. (2024b). Heart Failure Policy Framework: A National Action Plan For Change. Ottawa: HeartLife Foundation. Hellenic Statistical Authority. (2024). Health Statistics Report. Athens: ELSTAT. Hofmarcher, T., Berchet, C., Dedet, G. (2024). Access to oncology medicines in EU and OECD countries. OECD Health Working Papers No. 170, Paris: OECD. I INSEE. (2024). Espérance de vie à 35 ans par catégorie socioprofessionnelle et diplôme. Paris: INSEE. INSEE. (2025). Espérance de vie en 2024. Paris: INSEE. Institut national de santé publique du Québec (INSPQ). (n.d.). Québec Integrated Chronic Disease Surveillance System (QICDSS). Montreal: INSPQ. Institute for Health Metrics and Evaluation (IHME). (2023). Global Burden of Disease Study 2023. Seattle: University of Washington. Instituto Nacional de Estadística. (2021). Health expenditure by AC as % of GDP . Madrid: INE. International Agency for Research on Cancer. (n.d.). WHO International Agency for Research on Cancer. Lyon: IARC. ISTAT. (2024). System of Health Accounts (SHA). Rome: ISTAT. Italian Medicines Agency. (2023). National Report on Medicines use in Italy. Year 2022. Rome: The Medicines Utilisation Monitoring Centre. Italian Ministry of Health. (2024). National Diabetes Strategy. Rome: Ministry of Health. J JA PreventNCD. (2024). JA PreventNCD – Reducing Europe’s cancer and NCD burden through coordinated strategies on health determinants. Brussels: EU Health Programme. Japan Council for Quality Health Care (JCQHC). (2024). Minds Guideline Library. Tokyo: JCQHC. Japan Diabetes Society (JDS). (2018). Referral Standards for Patient Referral From Primary Physicians to Specialists and Specialty Medical Institutions. Tokyo: JDS.